Key facts
- Cleo’s last known valuation is $220.0M (Mar 2021).
- It has raised $84.0M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Gaingels, New Enterprise Associates, Felicis, Greylock, Foundation Capital — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Cleo
- ·The full record, as it builds
Funding rounds
No funding rounds for Cleo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cleo
Developer of a holistic family benefits platform designed for employee wellness and healthcare cost containment. The company's platform integrates a global network of certified care practitioners with an artificial intelligence-driven analytical suite to provide personalized coaching and concierge services, enabling enterprise employers and health plans to improve employee retention and mental health outcomes while reducing overall medical spend.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2016
- Employees
- 254
- Website
- hicleo.com/
- Ownership
- Privately Held (backing)
Cleo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cleo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cleo in its N-PORT filings yet. We sweep new filings monthly.